https://www.selleckchem.com/pr....oducts/favipiravir-t
The primary outcome occurred in 29.8% (28/94) of patients in the personalised management group, compared with 55.3% (52/94) of patients in the routine management group (relative risk 0.54, 95% confidence interval [CI] 0.38 to 0.77; absolute risk reduction -25.5%, 95% CI -39.2% to -11.9%; P0.001). One patient assigned to the personalised management group, compared with five assigned to the routine management group, died within 30 days after surgery (P=0.097). There were no clinically relevant differences between the two gro
Like
Comment
Share
